Morphometric properties of rat soleus and extensor digitorum longus muscles were studied 1 year following complete thoracic spinal cord transection (spinal cord level T9). Both muscles demonstrated almost complete type 1 to type 2 muscle fiber type conversion after 1 year. Muscle fiber atrophy was observed in both muscles. Type 2 fiber atrophy occurred to about the same extent in both muscles. Atrophy was most severe for the soleus type 1 fibers (50% decrease in size). Calculations based on the fiber type and size changes observed indicate that the percentage of the muscle cross-sectional area occupied by each fiber type was almost the same for both muscles 1 year after transection. Discriminant analysis of the data indicated that the percentage of type 2 fibers present in the muscle was the best discriminator between the various groups. These morphometric data provided a basis for understanding the contractile results presented in the previous study as well as insights into the mechanism of transformation in skeletal muscle. Furthermore, inherent differences between type 1 and type 2 fibers were demonstrated between predominantly slow and predominantly fast muscles. Thus, after almost one-half a lifetime of transection, rat muscles are almost completely transformed to fast muscle, and, regardless of initial conditions, have nearly identical properties.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0014-4886(86)90042-7 | DOI Listing |
Rehabil Nurs
December 2024
Center of Innovation for Complex Chronic Healthcare, Department of Veterans Affairs, Edward Hines Jr. VA Hospital, Hines, IL, USA.
Purpose: The study purpose was to develop and assess a simulation for registered nurses to apply knowledge, skills, and attitudes in conducting a focused assessment in the clinic setting to prevent community-acquired pressure injuries (CAPrIs) in individuals living with spinal cord injury (SCI).
Methods: Development, psychometric assessment, and pilot of a simulation for a nurse-patient clinic appointment to prevent CAPrIs at home. Evaluations were conducted via focus group.
Global Spine J
January 2025
Department of Spinal Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Study Design: Retrospective Cohort Study.
Objectives: The current recommended treatment for Giant Cell Tumour (GCT) of the spine is en bloc excision. Denosumab is a monoclonal antibody reducing osteoclast activity that shows promising results when used as a neo - adjuvant treatment.
Cell Rep
January 2025
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan. Electronic address:
Proteasomes generate antigenic peptides presented on cell surfaces-a process that, in neuroglia, is highly responsive to external stimuli. However, the function of the self-antigens presented by CNS parenchymal cells remains unclear. Here, we report that the fidelity of neuroglial self-antigens is crucial to suppress encephalitogenic T cell responses by elevating regulatory T (Treg) cell populations.
View Article and Find Full Text PDFNeuroradiol J
January 2025
Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, China.
Background: The spinal arteriovenous malformations (sAVMs) have been challenging entities to diagnose and treat. The small structure, important function, and complex vascular anatomy of the spinal cord increase the difficulty of treating sAVMs.
Objective: The combining holistic and local perspectives in the diagnosis and treatment of sAVMs were provided to teach spinal vascular anatomy and AVMs.
Eur Spine J
January 2025
Aix-Marseille University, CNRS, CRMBM, Marseille, France.
Background And Purpose: Degenerative cervical myelopathy (DCM) is the most common cause of spinal cord (SC) dysfunction. In routine clinical practice, SC changes are well depicted using conventional MRI, especially T2-weighted imaging. However, this modality usually fails to provide satisfactory clinico-radiological correlations.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!